Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Capital Expenditures (2016 - 2025)

Ekso Bionics Holdings has reported Capital Expenditures over the past 12 years, most recently at $126000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 500.0% to $126000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $188000.0, a 408.11% increase, with the full-year FY2025 number at $188000.0, up 408.11% from a year prior.
  • Capital Expenditures reached $126000.0 in Q4 2025 per EKSO's latest filing, up from $12000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $141000.0 in Q3 2022, with the low at -$1000.0 in Q4 2021.
  • The 5-year median for Capital Expenditures is $30500.0 (2024), against an average of $41071.4.
  • Peak YoY movement for Capital Expenditures: soared 5400.0% in 2022, then crashed 87.94% in 2023.
  • Tracing EKSO's Capital Expenditures over 5 years: stood at -$1000.0 in 2021, then soared by 5400.0% to $53000.0 in 2022, then decreased by 18.87% to $43000.0 in 2023, then tumbled by 51.16% to $21000.0 in 2024, then skyrocketed by 500.0% to $126000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $126000.0, $12000.0, and $40000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.